Editorial · 2015
Mini reviewPublished 2015
CAR-T: The Current and the Future
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chimeric antigen receptors (CARs) are recombinant receptors that are expressed on autologous T-cells. CAR-T usage has grown in recent years as a way to combat hematological and solid tumors. The purpose of this review is to describe new studies on CAR-T treatment along with our lab’s ideas on potential uses and pitfalls that could be investigated. The usage of TREG and antiCLTA4 as means for regulating CAR-T will also be looked at along with OX40, CD137 and CD27 receptors as means for increasing the efficacy of the treatment overall. In addition the usage of iCasp9 as a ‘suicide switch’ for the CAR-T treatment and the potential for a 4th generation CAR will be touched upon. Then the review will lead into talks about how such a treatment could be of potential use in treating solid and hematological cancer.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 10 Nov 2017
The newest medicine: Chimeric antigen receptor T-Cell immunotherapy (CAR-T)
Conference abstract · 29 Jun 2017
Potent anti-leukemia activities of chimeric antigen receptor modified T (CAR-T) cell therapy in Chinese patients with relapsed/refractory hematological malignances
Editorial · 2016
Comment on the Current CAR-T Technology
Perspective · 29 Jul 2024
CAR-T Cell Therapy in Cancer: Revolutionizing Immunotherapy for Precision Medicine
More from this journal
The newest in Pancreatic Disorders & Therapy.
Commentary · 27 May 2026
Systemic Inflammatory Spillover in Pancreatic Disease: Multiorgan Impact, Mediator Networks, and Clinical Consequences
Short communication · 27 May 2026
Immunometabolic Interactions in Pancreatic Disease: Crosstalk Between Energy Dysregulation, Immune Activation, and Tissue Dysfunction
Commentary · 27 May 2026
Microvascular Dysfunction in Pancreatic Disorders: Endothelial Injury, Perfusion Failure, and Tissue Consequences
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPancreatic Disorders & Therapy
- SubjectGastroenterology & Hepatology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Kunal Mishra”
- BylineArticles whose byline prints “Shu-Feng Zhou”
- BylineArticles whose byline prints “Jiazhi Sun”

